Charles Schwab’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-136,167
| Closed | -$630K | – | 3307 |
|
|
2019
Q1 | $630K | Sell |
136,167
-9,160
| -6% | -$43.4K | ﹤0.01% | 2679 |
|
|
2018
Q4 | $509K | Sell |
145,327
-6,429
| -4% | -$44.7K | ﹤0.01% | 2766 |
|
|
2018
Q3 | $1.53M | Buy |
151,756
+25,421
| +20% | +$203K | ﹤0.01% | 2507 |
|
|
2018
Q2 | $915K | Buy |
126,335
+31,840
| +34% | +$222K | ﹤0.01% | 2607 |
|
|
2018
Q1 | $571K | Buy |
94,495
+2,925
| +3% | +$24.2K | ﹤0.01% | 2695 |
|
|
2017
Q4 | $881K | Sell |
91,570
-13,242
| -13% | -$86.7K | ﹤0.01% | 2547 |
|
|
2017
Q3 | $931K | Buy |
104,812
+24,869
| +31% | +$257K | ﹤0.01% | 2526 |
|
|
2017
Q2 | $1.01M | Buy |
79,943
+475
| +0.6% | +$5.62K | ﹤0.01% | 2453 |
|
|
2017
Q1 | $836K | Buy |
79,468
+4,275
| +6% | +$45.5K | ﹤0.01% | 2479 |
|
|
2016
Q4 | $692K | Buy |
75,193
+3,850
| +5% | +$43.5K | ﹤0.01% | 2549 |
|
|
2016
Q3 | $842K | Sell |
71,343
-4,776
| -6% | -$72.6K | ﹤0.01% | 2449 |
|
|
2016
Q2 | $985K | Sell |
76,119
-98,129
| -56% | -$1.43M | ﹤0.01% | 2352 |
|
|
2016
Q1 | $2.79M | Buy |
174,248
+1,578
| +0.9% | +$30K | ﹤0.01% | 1879 |
|
|
2015
Q4 | $4.94M | Buy |
172,670
+96,900
| +128% | +$2.68M | 0.01% | 1526 |
|
|
2015
Q3 | $2.16M | Buy |
75,770
+15,381
| +25% | +$566K | ﹤0.01% | 2026 |
|
|
2015
Q2 | $2.17M | Buy |
60,389
+6,011
| +11% | +$187K | ﹤0.01% | 2037 |
|
|
2015
Q1 | $1.58M | Buy |
54,378
+7,614
| +16% | +$201K | ﹤0.01% | 2179 |
|
|
2014
Q4 | $986K | Buy |
46,764
+1,220
| +3% | +$24.1K | ﹤0.01% | 2355 |
|
|
2014
Q3 | $884K | Buy |
45,544
+16,144
| +55% | +$254K | ﹤0.01% | 2360 |
|
|
2014
Q2 | $460K | Sell |
29,400
-34,830
| -54% | -$563K | ﹤0.01% | 2661 |
|
|
2014
Q1 | $1.33M | Buy |
64,230
+42,630
| +197% | +$845K | ﹤0.01% | 2148 |
|
|
2013
Q4 | $279K | Hold |
21,600
| – | – | ﹤0.01% | 2838 |
|
|
2013
Q3 | $263K | Buy |
+21,600
| New | +$177K | ﹤0.01% | 2812 |
|
Other funds holding INSY
WS
Charles Schwab's INSY Position: Q2 2019 in Review
Charles Schwab sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 136,167 shares — an estimated $630K sold.
Charles Schwab first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $4.94M in Q4 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Charles Schwab reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Charles Schwab sold 136,167 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $630K.
- Charles Schwab first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- Charles Schwab's Insys Therapeutics, Inc. position peaked at $4.94M in Q4 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.